Topics

PERL concludes reduced uric acid has no impact on kidney disease in type 1 diabetes

19:00 EST 7 Nov 2019 | AAAS

(Joslin Diabetes Center) Three years of sustained reductions of blood levels of uric acid with the generic drug allopurinol did not benefit type 1 diabetes patients with mild to moderate kidney disease.

Original Article: PERL concludes reduced uric acid has no impact on kidney disease in type 1 diabetes

NEXT ARTICLE

More From BioPortfolio on "PERL concludes reduced uric acid has no impact on kidney disease in type 1 diabetes"

Quick Search

Relevant Topics

Gout
According to the National Arthritis Data Workgroup, an estimated 6 million people in the United States report having experienced gout at some point in their lives. In fact, gout is the most common form of inflammatory arthritis in men over the age of 40....

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...